Form 8-K - Current report:
SEC Accession No. 0001171843-25-005260
Filing Date
2025-08-11
Accepted
2025-08-11 07:00:46
Documents
72
Period of Report
2025-08-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_080925.htm   iXBRL 8-K 16703
2 PRESS RELEASE exh_991.htm EX-99.1 62109
3 EXHIBIT 99.2 exh_992.htm EX-99.2 20156
4 EXHIBIT 99.3 exh_993.htm EX-99.3 43403
5 exh992_01.jpg GRAPHIC 162310
6 exh992_02.jpg GRAPHIC 230236
7 exh992_03.jpg GRAPHIC 87196
8 exh992_04.jpg GRAPHIC 134511
9 exh992_05.jpg GRAPHIC 140498
10 exh992_06.jpg GRAPHIC 137289
11 exh992_07.jpg GRAPHIC 48191
12 exh992_08.jpg GRAPHIC 150033
13 exh992_09.jpg GRAPHIC 148794
14 exh992_10.jpg GRAPHIC 142148
15 exh992_11.jpg GRAPHIC 146586
16 exh992_12.jpg GRAPHIC 50560
17 exh992_13.jpg GRAPHIC 172248
18 exh992_14.jpg GRAPHIC 125078
19 exh992_15.jpg GRAPHIC 126472
20 exh992_16.jpg GRAPHIC 132739
21 exh992_17.jpg GRAPHIC 127651
22 exh992_18.jpg GRAPHIC 76871
23 exh993_01.jpg GRAPHIC 175733
24 exh993_02.jpg GRAPHIC 237375
25 exh993_03.jpg GRAPHIC 173352
26 exh993_04.jpg GRAPHIC 167894
27 exh993_05.jpg GRAPHIC 163168
28 exh993_06.jpg GRAPHIC 54332
29 exh993_07.jpg GRAPHIC 143742
30 exh993_08.jpg GRAPHIC 112092
31 exh993_09.jpg GRAPHIC 112520
32 exh993_10.jpg GRAPHIC 140638
33 exh993_11.jpg GRAPHIC 137110
34 exh993_12.jpg GRAPHIC 187300
35 exh993_13.jpg GRAPHIC 105423
36 exh993_14.jpg GRAPHIC 150160
37 exh993_15.jpg GRAPHIC 144470
38 exh993_16.jpg GRAPHIC 159821
39 exh993_17.jpg GRAPHIC 149341
40 exh993_18.jpg GRAPHIC 131382
41 exh993_19.jpg GRAPHIC 159323
42 exh993_20.jpg GRAPHIC 43766
43 exh993_21.jpg GRAPHIC 178720
44 exh993_22.jpg GRAPHIC 170472
45 exh993_23.jpg GRAPHIC 148423
46 exh993_24.jpg GRAPHIC 142201
47 exh993_25.jpg GRAPHIC 48191
48 exh993_26.jpg GRAPHIC 132752
49 exh993_27.jpg GRAPHIC 148106
50 exh993_28.jpg GRAPHIC 145502
51 exh993_29.jpg GRAPHIC 148978
52 exh993_30.jpg GRAPHIC 142164
53 exh993_31.jpg GRAPHIC 147931
54 exh993_32.jpg GRAPHIC 50560
55 exh993_33.jpg GRAPHIC 172269
56 exh993_34.jpg GRAPHIC 125104
57 exh993_35.jpg GRAPHIC 126510
58 exh993_36.jpg GRAPHIC 132761
59 exh993_37.jpg GRAPHIC 127687
60 exh993_38.jpg GRAPHIC 76871
  Complete submission text file 0001171843-25-005260.txt   10769245

Data Files

Seq Description Document Type Size
61 XBRL SCHEMA FILE gnw-20250101.xsd EX-101.SCH 3402
62 XBRL DEFINITION FILE gnw-20250101_def.xml EX-101.DEF 26066
63 XBRL LABEL FILE gnw-20250101_lab.xml EX-101.LAB 35956
64 XBRL PRESENTATION FILE gnw-20250101_pre.xml EX-101.PRE 24702
74 EXTRACTED XBRL INSTANCE DOCUMENT f8k_080925_htm.xml XML 3424
Mailing Address 80 GUEST STREET BOSTON MA 02135
Business Address 80 GUEST STREET BOSTON MA 02135 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39696 | Film No.: 251200094
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)